| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Molecular and Cellular Biology, July 2008, p. 4480-4493, Vol. 28, No. 14
0270-7306/08/$08.00+0 doi:10.1128/MCB.00375-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

,
Ilaria Guerini,
Nicola Manfrini,
Giovanna Lucchini, and
Maria Pia Longhese*
Dipartimento di Biotecnologie e Bioscienze, P.zza della Scienza 2, Università di Milano-Bicocca, 20126 Milan, Italy
Received 5 March 2008/ Returned for modification 21 April 2008/ Accepted 12 May 2008
DNA double-strand breaks (DSBs) can arise at unpredictable locations after DNA damage or in a programmed manner during meiosis. DNA damage checkpoint response to accidental DSBs during mitosis requires the Rad53 effector kinase, whereas the meiosis-specific Mek1 kinase, together with Red1 and Hop1, mediates the recombination checkpoint in response to programmed meiotic DSBs. Here we provide evidence that exogenous DSBs lead to Rad53 phosphorylation during the meiotic cell cycle, whereas programmed meiotic DSBs do not. However, the latter can trigger phosphorylation of a protein fusion between Rad53 and the Mec1-interacting protein Ddc2, suggesting that the inability of Rad53 to transduce the meiosis-specific DSB signals might be due to its failure to access the meiotic recombination sites. Rad53 phosphorylation/activation is elicited when unrepaired meiosis-specific DSBs escape the recombination checkpoint. This activation requires homologous chromosome segregation and delays the second meiotic division. Altogether, these data indicate that Rad53 prevents sister chromatid segregation in the presence of unrepaired programmed meiotic DSBs, thus providing a salvage mechanism ensuring genetic integrity in the gametes even in the absence of the recombination checkpoint.
Published ahead of print on 27 May 2008.
Present address: Division of Hepatology and Gene Therapy, Universidad de Navarra, 31008 Pamplona, Spain.
These two authors contributed equally to the work.
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|